The Critical Path Institute, a Tucson, Ariz.-based not-for-profit organization that aims to speed the development of medicines, named Dr. Carolyn Compton as president and CEO.
Critical Path Institute names Compton CEO
Compton succeeds C-Path founder Dr. Raymond Woosley, who announced last year his plans to step down, according to a news release from the organization. Compton most recently was director of the National Cancer Institute's office of biorepositories and biospecimen research and executive director of the Cancer Human BioBank. She is board-certified in anatomic pathology and clinical pathology.
C-Path was founded in 2005 with support from Science Foundation Arizona and the U.S. Food and Drug Administration, among others. The organization, which also has offices in Phoenix and in Rockville, Md., now has partnerships with 36 major pharmaceutical companies as well as scientists from government regulatory agencies, academia and patient advocacy groups, according to the release. Compton's age was unavailable at deadline.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.